Market Cap
$50.8B
EW
Edwards Lifesciences Corp
$85.00 ▼ -0.22%
Prev close $85.19Market cap$50.8B
ConsensusBuy
12-mo target$100.96 (+18.8%)
▲ Bullish
Analyst conviction 8/10
Insider Selling Cluster (5 insiders)High Impact Filing (8/10)36 New Institutional Positions14 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on EW right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Strong Buy (78%)
Inst. Holders
50 funds
Inst. Value
$36.6B
Inst. Activity
36 buys / 14 sells
Insider Activity
$0.00 buy / $11.2M sell
Insider Net $
-$11.2M
Social Sentiment
38° Cool
SEC Reports
19
Price chart 30d -6.4%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 30, 2026 short_volume
Short Volume: EW — 56.2% short (0.9M / 1.6M)
Short: 880,262 | Exempt: 276 | TRF Vol: 1,566,448 | Short Ratio: 56.2% | Off-exchange volume (dark p
Sep 14, 2026 Insider
Markowitz Wayne surrendered for taxes 568 shares
CVP, JAPAC @ $84.37 ($47.9K)
Sep 13, 2026 Insider
Dahl Andrew M. surrendered for taxes 253 shares
SVP, Corporate Controller @ $84.37 ($21.3K)
Sep 11, 2026 Insider
Aug 31, 2026 SEC Chopra Daveen surrendered for taxes 398 shares
CVP, TMTT, Surgical & IHFM @ $86.77 ($34.5K)
A cluster of four Edwards Lifesciences insiders sold a total of $507K in open-market sales over a 7-day window. All sale
CLUSTER — Impact 2/10
Three Edwards Lifesciences corporate VPs (CVP) sold a total of ~$457K in open-market sales over a 3-day window, with Dav
CLUSTER — Impact 2/10
Two Edwards Lifesciences corporate VPs sold a combined ~$219K in open-market shares on August 26, 2026, at ~$91.50. The
CLUSTER — Impact 2/10
Aug 10, 2026 Event
Edwards Lifesciences, et al v. Thompson, et al
Court ruling (ca10) — Docket: 25-01278
Analyst ratings buy % +9.9%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
78% rate it Buy or better · 40 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 11, 2026 | BTIG | REITERATE | Buy | 53% |
| Jul 25, 2026 | Leerink Partners | UPGRADE | Outperform | 49% |
| Jul 24, 2026 | JP Morgan | MAINTAIN | Overweight | 55% |
| Jul 24, 2026 | Piper Sandler | REITERATE | Overweight | 54% |
| Jul 16, 2026 | Truist Securities | MAINTAIN | Hold | 55% |
| Jul 15, 2026 | Mizuho | MAINTAIN | Outperform | 52% |
| Jul 13, 2026 | RBC Capital | MAINTAIN | Outperform | 55% |
| Jul 8, 2026 | Citigroup | MAINTAIN | Buy | 55% |
| Jul 6, 2026 | Evercore ISI Group | MAINTAIN | Outperform | 59% |
| Jun 30, 2026 | BTIG | MAINTAIN | Buy | 53% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 13 | 18 | 9 | 0 | 0 | 78% | |
| Aug 1, 2026 | 13 | 17 | 10 | 0 | 0 | 75% | |
| Jul 1, 2026 | 12 | 18 | 12 | 0 | 0 | 71% | |
| Jun 1, 2026 | 12 | 19 | 11 | 0 | 0 | 74% | |
| May 1, 2026 | 12 | 20 | 11 | 0 | 0 | 74% | |
| Apr 1, 2026 | 11 | 20 | 12 | 0 | 0 | 72% | |
| Mar 1, 2026 | 11 | 20 | 12 | 0 | 0 | 72% | |
| Feb 1, 2026 | 11 | 20 | 12 | 0 | 0 | 72% |
Price targets
Where 26 covering analysts think EW trades over the next 12 months.
$100.96 +18.8% upside Buy
Current$85.01 Low$84.00 Median$101.50 High$110.00 26 analysts
$84.00$110.00
Analyst rating Buy· 1.6/5 as of Oct 2, 2026
Social media sentiment mood -20.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
38°
Cool
BearishNeutralBullish
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
19 SEC filing reports analyzed · 2 bullish, 0 bearish, 0 mixed, 17 neutral · avg impact 2.8/10.
NEUTRALCLUSTER2/10
A cluster of four Edwards Lifesciences insiders sold a total of $507K in open-market sales over a 7-
Aug 31, 2026
NEUTRALCLUSTER2/10
Three Edwards Lifesciences corporate VPs (CVP) sold a total of ~$457K in open-market sales over a 3-
Aug 29, 2026
NEUTRALCLUSTER2/10
Two Edwards Lifesciences corporate VPs sold a combined ~$219K in open-market shares on August 26, 20
Aug 26, 2026
NEUTRALCOURT-RULING1/10
The Tenth Circuit dismissed as moot a former salesman's appeal of a preliminary injunction that enfo
Aug 13, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 30, 2026
short_volume
Short Volume: EW — 56.2% short (0.9M / 1.6M)
Short: 880,262 | Exempt: 276 | TRF Vol: 1,566,448 | Short Ratio: 56.2% | Off-exchange volume (dark pool + OTC)
Sep 29, 2026
short_volume
Short Volume: EW — 62.8% short (0.8M / 1.2M)
Short: 755,625 | Exempt: 1,682 | TRF Vol: 1,203,894 | Short Ratio: 62.8% | Off-exchange volume (dark pool + OTC)
Sep 17, 2026
short_volume
Short Volume: EW — 55.9% short (0.8M / 1.3M)
Short: 752,482 | Exempt: 5 | TRF Vol: 1,346,006 | Short Ratio: 55.9% | Off-exchange volume (dark pool + OTC)
Sep 7, 2026
dark_pool
Dark Pool: EW — 3.6M shares, 73,834 trades
Week starting 2026-09-07. Total ATS volume: 3,564,151 shares across 73,834 trades.
Aug 31, 2026
dark_pool
Dark Pool: EW — 4.0M shares, 80,258 trades
Week starting 2026-08-31. Total ATS volume: 3,979,814 shares across 80,258 trades.
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.74 | $0.72–$0.77 | 10.0% | +0.0% | 2↑ 15↓ | $1.7B | 23 |
| Next Q | $0.71 | $0.67–$0.76 | 21.8% | +0.0% | 0↑ 22↓ | $1.7B | 23 |
| Current FY | $3.00 | $2.96–$3.05 | 17.2% | +0.0% | 6↑ 14↓ | $6.8B | 28 |
| Next FY | $3.38 | $3.29–$3.46 | 12.6% | -0.0% | 17↑ 6↓ | $7.4B | 28 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.737 | — |
| 7d ago | $0.737 | — |
| 30d ago | $0.737 | — |
| 60d ago | $0.737 | -0.000 |
| 90d ago | $0.745 | -0.008 |
Institutional ownership
Which big funds own EW (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $36.6B total value (405,610,260 shares) as of 2026-Q2. Top holders: BlackRock,, VANGUARD, VANGUARD. Net buying activity: 36 institutions added/increased vs 14 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 58,789,433 | $5.3B | 14.5% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 37,615,952 | $3.4B | 9.3% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 26,411,402 | $2.4B | 6.5% | — |
| STATE STREET CORP | 26,321,940 | $2.4B | 6.5% | — |
| JPMORGAN CHASE & CO | 22,783,175 | $2.1B | 5.7% | — |
| WELLINGTON MANAGEMENT GROUP LLP | 16,827,967 | $1.5B | 4.2% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 15,437,251 | $1.4B | 3.8% | — |
| Bank of New York Mellon Corp | 14,084,483 | $1.3B | 3.5% | — |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 13,002,965 | $1.2B | 3.2% | — |
| Ninety One UK Ltd | 12,337,502 | $1.1B | 3.0% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| Aristotle Capital Management, LLC | NEW | — | 8,665,712 | — | $783.9M |
| FMR LLC | TRIM | 14,503,770 | 8,435,949 | -41.8% | $763.1M |
| NORGES BANK | NEW | — | 8,373,783 | — | $757.5M |
| ALLIANCEBERNSTEIN L.P. | DOUBLED | 3,467,355 | 8,660,416 | +149.8% | $693.5M |
| BANK OF AMERICA CORP /DE/ | ADD | 3,883,419 | 6,692,424 | +72.3% | $605.4M |
| Artisan Partners Limited Partnership | ADD | 5,201,144 | 6,625,703 | +27.4% | $599.4M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | DOUBLED | 1,890,859 | 5,677,344 | +200.3% | $513.6M |
| CITADEL ADVISORS LLC | DOUBLED | 519,031 | 3,997,925 | +670.3% | $361.7M |
| MILLENNIUM MANAGEMENT LLC | ADD | 1,796,821 | 3,584,795 | +99.5% | $324.3M |
| ROYAL BANK OF CANADA | ADD | 2,446,999 | 3,501,447 | +43.1% | $316.7M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
9 insiders, 50 transactions. Net -$11.2M — $0.00 bought, $11.2M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Markowitz Wayne | CVP, JAPAC | TAX W/H | 568 | $84.37 | $47.9K |
| Sep 13, 2026 | Dahl Andrew M. | SVP, Corporate Controller | TAX W/H | 253 | $84.37 | $21.3K |
| Sep 11, 2026 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | TAX W/H | 398 | $86.77 | $34.5K |
| Sep 11, 2026 | Lippis Daniel J. | CVP, TAVR | EXERCISE | 619 | $72.68 | $45.0K |
| Sep 11, 2026 | Lippis Daniel J. | CVP, TAVR | SELL | 619 | $87.51 | $54.2K |
| Sep 11, 2026 | Markowitz Wayne | CVP, JAPAC | TAX W/H | 355 | $86.77 | $30.8K |
| Aug 31, 2026 | Dahl Andrew M. | SVP, Corporate Controller | SELL | 544 | $91.06 | $49.5K |
| Aug 28, 2026 | Bruls Annette | CVP, EMEACLA | SELL | 2,644 | $89.98 | $237.9K |
| Aug 26, 2026 | Markowitz Wayne | CVP, JAPAC | SELL | 1,240 | $91.47 | $113.4K |
| Aug 26, 2026 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | EXERCISE | 31,800 | $72.68 | $2.3M |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for EW.
Shares short
9,088,401
Settlement Sep 15, 2026
Change vs prior
+0.7%
Semi-monthly cycle
Days to cover
3.1
At avg daily volume
Of shares outstanding
≈1.6%
Estimate — not % of float
All EW filing & press-release reports (19)
- CLUSTER reportAug 31, 2026
- CLUSTER reportAug 29, 2026
- CLUSTER reportAug 26, 2026
- COURT-RULING reportAug 13, 2026
- CLUSTER reportJul 30, 2026
- CLUSTER reportJul 29, 2026
- CLUSTER reportMay 29, 2026
- CLUSTER reportMay 18, 2026
- CLUSTER reportMay 18, 2026
- CLUSTER reportMay 12, 2026
- CLUSTER reportMay 12, 2026
- CLUSTER reportMay 12, 2026
- 8-K reportMay 8, 2026
- 8-K reportMay 4, 2026
- 8-K reportApr 23, 2026
- CLUSTER reportApr 7, 2026
- DEFA14A reportMar 26, 2026
- DEFA14A reportMar 26, 2026
- INST-CLUSTER reportFeb 28, 2026